[Federal Register Volume 85, Number 50 (Friday, March 13, 2020)]
[Notices]
[Page 14686]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-05096]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the Board of Scientific 
Counselors, NIDA.
    The meeting will be closed to the public as indicated below in 
accordance with the provisions set forth in sections 552b(c)(4) and 
552b(c)(6), Title 5 U.S.C., as amended for the review, discussion, and 
evaluation of individual intramural programs and projects conducted by 
the NATIONAL INSTITUTE ON DRUG ABUSE, including consideration of 
personnel qualifications and performance, and the competence of 
individual investigators, the disclosure of which would constitute a 
clearly unwarranted invasion of personal privacy.

    Name of Committee: Board of Scientific Counselors, NIDA.
    Date: May 7-8, 2020.
    Time: 8:00 a.m. to 3:15 p.m.
    Agenda: To review and evaluate personnel qualifications and 
performance, and competence of individual investigators.
    Place: Intramural Research Program, Biomedical Research Center, 
Johns Hopkins Bayview Campus, 251 Bayview Boulevard, Room BRC 
03C219, Baltimore, MD 21224.
    Contact Person: Joshua Kysiak, Program Specialist, Biomedical 
Research Center, Intramural Research Program, National Institute on 
Drug Abuse, NIH, DHHS, 251 Bayview Boulevard, Baltimore, MD 21224, 
443-740-2465, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug 
Abuse Scientist Development Award for Clinicians, Scientist 
Development Awards, and Research Scientist Awards; 93.278, Drug 
Abuse National Research Service Awards for Research Training; 
93.279, Drug Abuse and Addiction Research Programs, National 
Institutes of Health, HHS)

    Dated: March 9, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-05096 Filed 3-12-20; 8:45 am]
 BILLING CODE 4140-01-P